Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on October 29, 2026

Oct. 29, 2026

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Acrivon Announces Late-Breaking Oral Plenary Presentation of Early Phase 1/2 Clinical Results in AP3-Predicted Tumors for its First-in-Class WEE1/PKMYT1 Inhibitor ACR-2316 at the 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

Oct. 29, 2026

Verano Celebrates Grand Opening of Newest Affiliated Dispensary, Zen Leaf Ephrata, Relocated to Prime New Location in Pennsylvania

Indeterminate GlobeNewswire

Oct. 29, 2026

Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics

Indeterminate GlobeNewswire

Oct. 29, 2026

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Oct. 29, 2026

Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Immutep Quarterly Activities Report Q1 FY27

Indeterminate GlobeNewswire

Oct. 29, 2026

SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference

Indeterminate GlobeNewswire

Oct. 29, 2026

MediWound to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

VYSTAR ENTERS STRATEGIC PARTNERSHIP INTO THE MOTION PICTURE INDUSTRY, WITH FILM AND TOKENIZATION CONTRACTS

Indeterminate GlobeNewswire

Oct. 29, 2026

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

Indeterminate GlobeNewswire

Oct. 29, 2026

Davion Healthcare PLC Agrees $13.5 Million Acquisition of Profitable US Home Healthcare Business

Indeterminate GlobeNewswire

Oct. 29, 2026

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Oct. 29, 2026

Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ™ in Recurrent Glioblastoma

Indeterminate GlobeNewswire

Oct. 29, 2026

Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

Indeterminate GlobeNewswire

Oct. 29, 2026

Ocugen to Participate in Upcoming November Investor and Industry Conferences

Indeterminate GlobeNewswire

Oct. 29, 2026

Novastra Therapeutics to Present First-in-Human Data for OAP-101 in Checkpoint-Refractory Advanced Melanoma at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Sironax Announces Three Abstracts on SARM1 Inhibitor SIR2501 Selected for Presentation at Neuroscience 2026

Indeterminate GlobeNewswire